Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Hes6 drives a network with therapeutic potential in castrate-resistant prostate cancer
PubMed Full text in PMC Similar studies Analyze with GEO2R
Hes6 drives a critical AR transcriptional program to induce castration resistant prostate cancer through activation of an E2F1-mediated cell cycle network
PubMed Full text in PMC Similar studies SRA Run Selector
Hes6 expression is controlled by c-Myc and the AR to promote E2F1 activity and poor outcome in castrate-resistant prostate cancer (cMyc ChIP-seq)
PubMed Full text in PMC Similar studies
Hes6 expression is controlled by c-Myc and the AR to promote E2F1 activity and poor outcome in castrate-resistant prostate cancer (E2F1 ChIP-seq)
Hes6 expression is controlled by c-Myc and the AR to promote E2F1 activity and poor outcome in castrate-resistant prostate cancer (LNCaP)
Hes6 expression is controlled by c-Myc and the AR to promote E2F1 activity and poor outcome in castrate-resistant prostate cancer (xenografts)
Investigation of the AR cistrome in response to RB depletion in castration-resistant prostate cancer
Identification of ZBTB7A cistrome and transcriptome profiles in VCaP prostate cancer cells
RNA-seq with knockdown ZBTB7A and NTC control
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
ZBTB7A ChIP-seq under different DHT level
Expression correlates of the full-length androgen receptor and its splicing variants
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq]
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [ChIP-seq]
Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
Expression data from control and COUP-TFII siRNA treated HUVEC cells
Gene expression in benign and prostate cancer tissue
PubMed Similar studies Analyze with GEO2R
The androgen receptor induces a distinct transcriptional program in castration resistant prostate cancer in man
PubMed Similar studies
Whole genome expression analysis of clinical bone metastasis samples
AR-V7 Targets in Castration-Resistant Prostate Cancer (CRPC) Cell Line
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on